CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reiterated its "I4 2012" goals and long-term financial guidance, reviewed recent clinical and business achievements, and announced full year and fourth quarter 2008 financial results.
